...
首页> 外文期刊>World neurosurgery >Delayed Catheter-Related Intracranial Hemorrhage After a Ventriculoperitoneal or Ventriculoatrial Shunt in Hydrocephalus
【24h】

Delayed Catheter-Related Intracranial Hemorrhage After a Ventriculoperitoneal or Ventriculoatrial Shunt in Hydrocephalus

机译:在脑积水脑室或心室分流后延迟导管相关的颅内出血

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective Delayed catheter-related intracranial hemorrhage is not rare after a ventriculoperitoneal (VP) or ventriculoatrial (VA) shunt for the treatment of hydrocephalus. Immediate postoperative catheter-related intracranial hemorrhage is possibly due to the procedure itself; however, delayed intracranial hemorrhage may have other underlying mechanisms. This study aimed to investigate the clinical characteristics and reveal the risk factors of delayed catheter-related intracranial hemorrhage after a VP or VA shunt. Methods We did a retrospective study to review patients with hydrocephalus and underwent VP or VA shunt in our department from September 2011 to December 2015. We reviewed the clinical characteristics of the patients with delayed catheter-related intracranial hemorrhage, and its risk factors were analyzed with SPSS 16.0. Results Of the 218 patients enrolled in the study (145 male, 73 female), 17 (7.8%) patients experienced delayed catheter-related intracranial hemorrhage, including 11 of 151 (7.3%) patients with a VP shunt and 6 of 67 (9.0%) patients with a VA shunt. Additionally, 4 of the 16 patients with postoperative low-molecular-weight heparin (LMWH) therapy and 13 of the 202 patients without LMWH experienced bleeding, showing a significant difference (25% vs. 6.4%, P ?= 0.026). The relative risk was 4.8 (95% confidence interval: 1.4–17.1). Conclusion Delayed catheter-related intracranial hemorrhage is not rare after a VP or VA shunt. However, most patients can be cured after appropriate treatment. Postoperative anticoagulation therapy with enoxaparin may be associated with an increased risk of bleeding.
机译:目的延迟导管相关的颅内出血在脑室(VP)或脑室(VA)分流治疗脑积水后不罕见。术后导管相关的颅内出血可能是由于手术本身;然而,延迟颅内出血可能具有其他潜在的机制。本研究旨在探讨VP或VA分流后延迟导管相关颅内出血的临床特征,揭示延迟导管相关的颅内出血。方法采用回顾性研究,从2011年到2011年9月到2015年12月,我们部门在我们的部门进行了脑积水和vp或Va分流的患者。我们审查了延迟导管相关颅内出血的患者的临床特征,并分析了其风险因素SPSS 16.0。患有该研究的218例患者(145名男性,73名女性),17例(7.8%)患者经历了延迟导管相关的颅内出血,其中151例(7.3%)患者的VP分流患者,共67名(9.0 %)VA分流的患者。另外,16名术后低分子量肝素(LMWH)治疗中的4例中有4例和202例患者中的13例没有LMWh经历过出血,显示出显着差异(25%与6.4%,P?= 0.026)。相对风险为4.8(95%置信区间:1.4-17.1)。结论延迟导管相关的颅内出血在VP或VA分流后不罕见。然而,大多数患者在适当的治疗后可以固化。术后抗凝血治疗烯脱蒿素可能与出血风险增加有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号